AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.
Sources
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
AstraZeneca pauses £200m Cambridge investment
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
Latest News
14:06
Trump says Ukraine could receive a license to produce a less advanced version of Patriot missiles
14:06
The Minister of Economy proposes measures to revive tourism in 2027
13:40
MIPE: The final results of the PNRR will be available after the submission of the last payment request to the European Commission
13:35
SPECIAL Informat.ro / From the Arctic to the Black Sea: why the summit in Rovaniemi matters for Romania
13:29
Nicușor Dan announces the deepening of cooperation with Finland in air defense, following the visit to Lapland Air Base
See more news